Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

Clinical trial NCT01687595 · COMPLETED

Trial details

NCT number: NCT01687595
Sponsor: Agenus Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Herpes Simplex Type 2

Start date: 2012-10-29
Primary completion: 2013-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.